Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Seripa

Showing results (51-60 of 225) with videos related to

Pageof 23
Sort By:
Expert Review of Neurotherapeutics|April 12, 2019
Disease-modifying therapies for tauopathies: agents in the pipelineFrancesco Panza, Bruno P Imbimbo, Madia Lozupone, et al.
Ageing Research Reviews|July 19, 2011
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's diseaseFrancesco Panza, Vincenza Frisardi, Davide Seripa, et al.
Age (Dordrecht, Netherlands)|June 23, 2011
Klotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysisGiulia Paroni, Davide Seripa, Francesco Panza, et al.
Aging Clinical and Experimental Research|September 12, 2020
Clinical and demographic parameters predict the progression from mild cognitive impairment to dementia in elderly patientsGiovanni Zuliani, Michele Polastri, Tommaso Romagnoli, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2017
Cognitive frailty: a potential target for secondary prevention of dementiaFrancesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
European Journal of Human Genetics : EJHG|January 29, 2009
The complex interaction between APOE promoter and AD: an Italian case-control studyAlessandra Bizzarro, Davide Seripa, Adele Acciarri, et al.
Neurochemistry International|May 9, 2024
High plasma homocysteine levels predict the progression from mild cognitive impairment to dementiaGiovanni Zuliani, Gloria Brombo, Michele Polastri, et al.
Ageing Research Reviews|May 7, 2010
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's diseaseVincenza Frisardi, Vincenzo Solfrizzi, Davide Seripa, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Treatment of late-life major depressive disorder with selective serotonin reuptake inhibitors improves the multidimensional prognostic indexAlberto Pilotto, Grazia D'Onofrio, Francesco Panza, et al.
Nutrients|May 13, 2018
Neurocognitive Disorders and Dehydration in Older Patients: Clinical Experience Supports the Hydromolecular Hypothesis of DementiaMichele Lauriola, Antonio Mangiacotti, Grazia D'Onofrio, et al.
Pageof 23

Showing results (51-60 of 225) with videos related to

Sort By:
Pageof 23
Expert Review of Neurotherapeutics|April 12, 2019
Disease-modifying therapies for tauopathies: agents in the pipelineFrancesco Panza, Bruno P Imbimbo, Madia Lozupone, et al.
Ageing Research Reviews|July 19, 2011
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's diseaseFrancesco Panza, Vincenza Frisardi, Davide Seripa, et al.
Age (Dordrecht, Netherlands)|June 23, 2011
Klotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysisGiulia Paroni, Davide Seripa, Francesco Panza, et al.
Aging Clinical and Experimental Research|September 12, 2020
Clinical and demographic parameters predict the progression from mild cognitive impairment to dementia in elderly patientsGiovanni Zuliani, Michele Polastri, Tommaso Romagnoli, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 30, 2017
Cognitive frailty: a potential target for secondary prevention of dementiaFrancesco Panza, Madia Lozupone, Vincenzo Solfrizzi, et al.
European Journal of Human Genetics : EJHG|January 29, 2009
The complex interaction between APOE promoter and AD: an Italian case-control studyAlessandra Bizzarro, Davide Seripa, Adele Acciarri, et al.
Neurochemistry International|May 9, 2024
High plasma homocysteine levels predict the progression from mild cognitive impairment to dementiaGiovanni Zuliani, Gloria Brombo, Michele Polastri, et al.
Ageing Research Reviews|May 7, 2010
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's diseaseVincenza Frisardi, Vincenzo Solfrizzi, Davide Seripa, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Treatment of late-life major depressive disorder with selective serotonin reuptake inhibitors improves the multidimensional prognostic indexAlberto Pilotto, Grazia D'Onofrio, Francesco Panza, et al.
Nutrients|May 13, 2018
Neurocognitive Disorders and Dehydration in Older Patients: Clinical Experience Supports the Hydromolecular Hypothesis of DementiaMichele Lauriola, Antonio Mangiacotti, Grazia D'Onofrio, et al.
Pageof 23